Results of a Phase II clinical trial conducted at The University of Texas MD Anderson Cancer Center revealed that combination targeted therapy, consisting of rituximab, lenalidomide and ibrutinib (RLI), had an 84.6 percent overall response rate (ORR) and 38.5 percent complete response rate (CRR) when given prior to any chemotherapy for newly diagnosed patients with a specific type of diffuse large b-cell lymphoma (DLBCL).
* This article was originally published here
Tuesday 4 June 2019
'Slothbot' takes a leisurely approach to environmental monitoring
For environmental monitoring, precision agriculture, infrastructure maintenance and certain security applications, slow and energy efficient can be better than fast and always needing a recharge. That's where "SlothBot" comes in.
* This article was originally published here
* This article was originally published here
California maintains life science dominance, report finds
California retains the crown as the nation's top recipient of federal life science funding, signifying the industry's dynamism, according to a new report from Biocom, a California life science trade group.
* This article was originally published here
* This article was originally published here
Ant reactions to habitat disruptions inform a result of evolution
A Concordia biology professor is calling on ant experts to develop a set of common principles that influence the way the insects respond when their habitat undergoes severe disruption.
* This article was originally published here
* This article was originally published here
Agent Unicorn headset for ADHD children may make understanding easier
The quest for a better understanding among scientists of children with attention deficit hyperactivity disorder (ADHD) goes on.
* This article was originally published here
* This article was originally published here
More states sue opioid maker alleging deceptive marketing
California, Hawaii, Maine and the District of Columbia filed lawsuits Monday against the maker of OxyContin and the company's former president, alleging the firm falsely promoted the drug by downplaying the risk of addiction while it emerged as one of the most widely abused opioids in the U.S.
* This article was originally published here
* This article was originally published here
Allo-HCT with unrelated donor tied to better outcomes in AML
(HealthDay)—Allogeneic hematopoietic cell transplantation (allo-HCT) with an unrelated donor (UD) results in better transplantation outcomes than cord blood transplantation (CBT) in acute myeloid leukemia (AML) patients with active disease, according to a study recently published in the Blood Cancer Journal.
* This article was originally published here
* This article was originally published here
Hydrogen-power electric flying vehicle: Long road to liftoff
A transportation company is betting its sleek new hydrogen-powered electric flying vehicles will someday serve as taxis, cargo carriers and ambulances of the sky, but experts say they will have to clear a number of regulatory hurdles before being approved for takeoff years in the future.
* This article was originally published here
* This article was originally published here
Patent talk: Apple has foldables, durability on its mind
Fact of life: Consumers chase the new and shiny, at least enough of them to justify constant trade-ins and barely necessary purchases.
* This article was originally published here
* This article was originally published here
In the long run, funny women satisfy men more
Yes, women expect men who are courting them to make them laugh. But a woman who can make her partner laugh is equally, if not more, important to the guy's long-term happiness in the relationship.
* This article was originally published here
* This article was originally published here
Apple iTunes to play last song
Apple on Monday announced the demise of its groundbreaking iTunes platform in favor of three more tailored apps, as it refines its offerings to be a stage for digital music, films, podcasts and more.
* This article was originally published here
* This article was originally published here
Shared control allows a robot to use two hands working together to complete tasks
A team of researchers from the University of Wisconsin and the Naval Research Laboratory has designed and built a robotic system that allows for bimanual robot manipulation through shared control. In their paper published in the journal Science Robotics, the group explains the ideas behind their work and how well they worked in practice.
* This article was originally published here
* This article was originally published here
India rubbish mountain to rise higher than Taj Mahal
India's tallest rubbish mountain in New Delhi is on course to rise higher than the Taj Mahal in the next year, becoming a fetid symbol for what the UN considers the world's most polluted capital.
* This article was originally published here
* This article was originally published here
Energy storage project in Utah described as world's largest of its kind
Mitsubishi Hitachi Power Systems (MHPS) announced an ambitious energy storage project to develop what it claims will be the world's largest energy storage project of its kind, in Utah. Renewable hydrogen is at the core.
* This article was originally published here
* This article was originally published here
Immunotherapy better than aggressive chemo as first-line treatment in head and neck cancer
Immunotherapy used with chemotherapy or on its own is a better first-line treatment for people with head and neck cancer that has returned than standard aggressive chemotherapy, new clinical trial results show.
* This article was originally published here
* This article was originally published here
Subscribe to:
Posts (Atom)